Mfg Part Number
Ab03296-1.159-BS
Vector Labs Ab03296-1.159-BS Anti-Ricin [A9], Mouse IgG1-Fc Fusion, (1 mg)
Quick Overview
The original antibody was generated by immunizing two alpacas with a ricin toxoid. A VHH phage-displayed library was constructed and the antibody was identified in a panning directly on plate bound RTA.
$5,162.30
Order will ship within 1-3 business days
| Product Class: | Purified |
|---|---|
| Clone ID: | A9 |
| Synonyms: | rRNA N-glycosidase; Ricin A chain (EC:3.2.2.22); Ricin B chain |
| Amount: | 1 mg |
| Application Codes Clone: | Crystallography; ELISA; Neutralizing |
| Shipping Temperature: | Wet Ice |
| Origin Pub PMID: | 6CWG |
| Buffer Composition: | PBS only. |
| Original Format: | VHH |
| Storage Temperature: | Store at 4⁰C for up to 3 months. Note, this antibody is provided without added preservatives, it is therefore recommed this antibody be handled under sterile conditions. For longer storage, aliquot and store at -20⁰C. |
| Specificity Statement: | The antibody recognizes an epitope on RTA that straddles clusters I and III. In particular, the antibody contacts the core secondary structural elements of cluster I, namely β-strand h, α-helix B and α-helix D, as well as a core element of cluster III, namely α-helix C. Ricin is a member of the type II ribosome-inactivating protein (RIP) family of plant toxins. It is a 65 kDa glycoprotein consisting of two subunits, RTA and RTB, joined by a single disulfide bond. |
| Application Notes: | The VHH antibody was specific for RTA as confirmed by competition ELISA. The crystal structure of ricin catalytic subunit in complex with the VHH antibody was determined. The antibody had relatively weak toxin-neutralizing activity (IC50 ~750 nM), as shown by Vero cell cytotoxicity assays. The antibody binding affinity (KD) for ricin holotoxin (0.08 nM). The binding affinity, and, toxin-neutralizing activity of the antibody was mediated by CDR2 containing five consecutive Gly residues that interact with α-helix B. In order to prove this, a variant of the antibody lacking Gly AC151residue 59 (A9Δ59) was generated. Binding studies and toxinneutralizing assays confirmed that the removal of a single glycine residue from A9’s CDR2 significantly reduced binding affinity for RTA (~10-fold weaker; 1.76 nM versus 0.102 nM) and eliminated toxin-neutralizing activity (Rudolph et al., 2018; PMID: 30265352). |
| Brand | Vector Labs |
|---|---|
| UNSPSC | 12161500 |